By: Zurriya Faran, PharmD Candidate c/o 2031

The visible loss of skin pigmentation often indicates vitiligo, but what happens beneath the surface is far more complex. Traditionally, vitiligo has been explained as an autoimmune disease in which the immune system mistakenly attacks pigment-producing cells. However, newer research suggests that one of the key factors driving this condition is oxidative stress, a process that may actually initiate the disease rather than simply accompany it. Studies have shown that patients with vitiligo have significantly higher levels of oxidative stress markers, including hydrogen peroxide, in affected skin, supporting the idea that oxidative damage occurs early in disease development.¹

Oxidative stress occurs when harmful molecules, known as free radicals, build up in the body and overwhelm its natural defenses. More specifically, reactive oxygen species (ROS) such as hydrogen peroxide (H₂O₂) accumulate when antioxidant systems like catalase and glutathione fail to neutralize them.³ When this imbalance occurs in the skin, it can damage melanocytes, the cells that produce pigment. This damage is not just a minor issue—it may involve mitochondrial dysfunction, lipid peroxidation, and apoptosis (programmed cell death), all of which weaken melanocyte survival.²

When melanocytes are injured, they release “danger signals,” known as damage-associated molecular patterns (DAMPs), including proteins such as HSP70. These signals activate the immune system, particularly cytotoxic CD8⁺ T cells, which begin targeting melanocytes as if they were harmful invaders.⁴ This marks the transition from oxidative damage to an autoimmune response, ultimately leading to the destruction of pigment cells and the formation of the characteristic white patches seen in vitiligo.

This process helps explain an important idea: oxidative stress may be the starting point of vitiligo’s autoimmune response. Instead of the immune system randomly attacking pigment cells, oxidative stress may trigger the immune system in the first place by exposing melanocyte antigens and promoting inflammatory signaling pathways.²

Understanding this connection is important because it opens the door to new treatment approaches. If researchers can find ways to reduce oxidative stress or strengthen the body’s antioxidant defenses, they may be able to slow or even prevent the progression of vitiligo. Current approaches include antioxidant therapy, activation of the Nrf2 pathway to restore redox balance, and combining antioxidants with phototherapy to improve repigmentation outcomes.²

Looking ahead, future research on early oxidative damage and immune signaling pathways may lead to more targeted, preventive treatments, potentially improving long-term outcomes for patients with vitiligo.

References:

1. An R, Li D, Dong Y, et al. Methylcobalamin Protects Melanocytes from H2O2-Induced Oxidative Stress by Activating the Nrf2/HO-1 Pathway. Drug Design, Development and Therapy. 2021;15:4837-4848.
2. Cui T, Weigang Z, Shuli L, Xuguang C. Shibboleth Authentication Request. Stjohns.edu. Published 2026. Accessed April 16, 2026. https://www-sciencedirect-com.jerome.stjohns.edu/science/article/pii/S0022202X19314794?via%3Dihub
3. İnce Z, Kutlu B, Bozali K, Yılmaz N, Cengiz FP, Güler EM. Evaluation of oxidative stress levels as biomarkers in vitiligo patients. Turkish Journal of Dermatology. 2023;17(4):132-135. doi:10.4103/tjd.tjd_95_23
4. Xuan Y, Yang Y, Xiang L, Zhang C. The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death. Oxidative medicine and cellular longevity. 2022;2022:8498472. doi:10.1155/2022/8498472